In the News
GRAIL Announces Collaborations with Amgen, AstraZeneca, and Bristol Myers Squibb to Evaluate Cancer Early Detection Technology for Minimal Residual Disease
GRAIL today announced a collaboration with global biopharmaceutical companies Amgen, AstraZeneca, and Bristol Myers Squibb to evaluate GRAIL’s methylation-based technology for the detection of minimal residual disease (MRD). Cancer MRD testing is used in clinical and research applications to detect the presence or...
GRAIL Confirms Q2 2021 Introduction of Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test
GRAIL has confirmed that it expects to introduce Galleri™, its multi-cancer early detection blood test, in the second quarter of 2021. In December 2020, GRAIL completed the enrollment of PATHFINDER, a prospective, 6,600-participant multi-site interventional study conducted under a U.S. Food and Drug Administration...
McKesson Ventures Expands Portfolio Development Team and Invests in Market Research
McKesson Ventures has added Lizzie Lee as its newest team member. She joins the firm as senior director, leading its portfolio development and market research efforts. With a decade of healthcare experience, Lee is well-positioned to help McKesson Ventures’ portfolio companies scale by developing and facilitating...
Aspen RxHealth Raises $23M Series B Funding Round Led by Bessemer Venture Partners
Aspen RxHealth, developer of a first-of-its-kind clinical pharmacy model developed by pharmacists for pharmacists that delivers value for health plans and risk-bearing providers, today announced the closure of a $23 million Series B funding round led by Bessemer Venture Partners, with participation from other...
The Future of Care Demands a Virtual Health Ecosystem
Telehealth usage skyrocketed in the early stages of the COVID-19 pandemic. According to data from EHR vendor Epic Systems, telehealth visits peaked in mid-April, when telehealth accounted for 69 percent of all ambulatory care visits. Although the percentage dropped to 21 percent by mid-July, telehealth usage is still...
Is the COVID Vaccine the Shot in the Arm We Need for Healthcare Access?
Colin Hung recently interviewed Chris Gervais, CTO and CSO at Kyruus; and Pamela Landis, vice president of digital engagement at Hackensack Meridian Health, for a discussion of healthcare access and the importance of that access in light of the COVID-19 pandemic. Gervais began by saying that Kyruus defines patient...
Andrew Dudum, Hims & Hers, on disrupting healthcare by reimagining the patient experience
On a recent episode of Wharton Digital Health’s The Pulse podcast, Hims & Hers Founder and CEO Andrew Dudum discussed a wide range of topics including how Hims & Hers disrupted the $4 trillion healthcare industry by creating a telehealth tool that makes Americans’ medical care more affordable, more...
McKesson Launches Ontada, an Oncology Technology and Insights Business Dedicated to Help Advance Cancer Research and Care
McKesson Corporation today announced the launch of Ontada, an oncology technology and insights business designed to support innovation, acceleration, and evidence generation to drive better outcomes for patients with cancer. Building on McKesson’s long history in community oncology, Ontada combines its real-world...
McKesson Ventures Invests as Clinical Ink Debuts Lunexis™ ePRO+ Solution
Clinical Ink, a global clinical trial technology company, today announced an investment from McKesson Ventures, along with its significantly enhanced electronic patient reported outcome (ePRO) module. “McKesson Ventures is excited to invest in Clinical Ink, a market leader in clinical trial enablement technology,”...
Michelle Snyder, Digital Health Veteran, Joins McKesson Ventures
McKesson Ventures has hired Michelle Snyder as its newest investment partner. Snyder, a mobile health pioneer, is known for her leadership and guidance in building Epocrates, one of the healthcare industry’s first successful mobile health companies. She brings more than 25 years of healthcare experience to the...
Press Releases
Aledade Announces Carbon Neutrality, Additional Sustainability Efforts
On Earth Day 2021, Aledade announced three key sustainability commitments the company is making in an effort to reduce its carbon footprint and support a healthier environment. First among them, Aledade announced that, effective immediately, the company is...
Evidation Partners with HealthVerity to Enhance its Research and Virtual Health Offerings
Evidation and HealthVerity have announced a collaboration to provide greater transparency to the patient experience by allowing individuals to connect their wearable and survey data with real-world data from clinical settings via HealthVerity. The partnership will...
Clinical Ink Deploys eCOA Solutions for Industry’s Most Complex Assessments
Global clinical trial technology company Clinical Ink announced that it has deployed an industry-leading 500 unique eCOA scales and assessments in 82 languages. eCOA, or electronic clinical outcome assessment, instruments play a critical role in clinical trial conduct...
Health Care Transformation Task Force Expands its Executive Committee
Aledade Chief Commercial Officer and Chief Policy Officer Sean Cavanaugh is one of five people recently elected to the Executive Committee of the Health Care Transformation Task Force. The Health Care Transformation Task Force (HCTTF) is a group of leading payers,...
Accolade to Announce Fiscal Fourth Quarter and Full Year 2021 Financial Results
Accolade, which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, announced that it will release fiscal fourth quarter and full year 2021 financial results...